Meral Beksac (@mbeksac56) 's Twitter Profile
Meral Beksac

@mbeksac56

Professor of Hematology, Ankara Liv Hosp, Istinye Univ, TurkHemSociety MM committee chair( MmGTr), EMN senior board , EBMT PCD vice chair, BMSG vice president

ID: 2171123355

calendar_today06-11-2013 18:14:46

3,3K Tweet

1,1K Followers

415 Following

International Myeloma Foundation (@imfmyeloma) 's Twitter Profile Photo

The IMF's International Myeloma Working Group Summit is coming up! Global experts will unite to advance research, treatment & collaborate with leading myeloma specialists worldwide to develop consensus guidelines for diagnosing & treating myeloma. #IMFIMWG #NCRM25 Shaji Kumar

Robert Z. Orlowski (@myeloma_doc) 's Twitter Profile Photo

#Myeloma Paper of the Day: New light chain #MGUS definition -> 1.54% prevalence (1.46-1.63) using standard & 0.27% (0.23-0.30) w/ revised intervals; 0/1006 persons meeting LC-MGUS criteria w/ standard but not based on revised intervals progressed: pubmed.ncbi.nlm.nih.gov/40440024/. #mmsm

#Myeloma Paper of the Day: New light chain #MGUS definition -> 1.54% prevalence (1.46-1.63) using standard & 0.27% (0.23-0.30) w/ revised intervals; 0/1006 persons meeting LC-MGUS criteria w/ standard but not based on revised intervals progressed: pubmed.ncbi.nlm.nih.gov/40440024/. #mmsm
ASH (@ash_hematology) 's Twitter Profile Photo

New ICD-10-CM codes for the Duffy phenotype have recently been released. What are the implications for patients and what does this mean for healthcare? Learn more: ow.ly/YGRq50W2Qmp #DuffyNull #Hematology #DANC #ASHEducation

New ICD-10-CM codes for the Duffy phenotype have recently been released. What are the implications for patients and what does this mean for healthcare?  

Learn more: ow.ly/YGRq50W2Qmp  

#DuffyNull #Hematology #DANC #ASHEducation
Vincent Rajkumar (@vincentrk) 's Twitter Profile Photo

Just out: Mayo Clinic mSMART Risk Stratification of Myeloma #EHA25 1/ We recommend and use same high risk cytogenetic definition as the latest IMS/IMWG paper 2/ Primary plasma cell leukemia is high risk myeloma 3/ We define Double-hit high risk myeloma msmart.org/mm-treatment-g…

Just out: Mayo Clinic mSMART Risk Stratification of Myeloma
#EHA25

1/ We recommend and use same high risk cytogenetic definition as the latest IMS/IMWG paper

2/ Primary plasma cell leukemia is high risk myeloma

3/ We define Double-hit high risk myeloma

msmart.org/mm-treatment-g…
Bruno Paiva (@brunopaiva_unav) 's Twitter Profile Photo

#EHA2025 lifetime achievement award to Jesús San Miguel; my boss, mentor, friend, wedding planner and second-father! 18 years ago I was blessed by start working under his leadership, and I'm looking forward to the next 18 years! #mmsm Clínica Universidad de Navarra Cima Universidad de Navarra @sehh_es PETHEMA

#EHA2025 lifetime achievement award to Jesús San Miguel; my boss, mentor, friend, wedding planner and second-father! 18 years ago I was blessed by start working under his leadership, and I'm looking forward to the next 18 years!
#mmsm
<a href="/ClinicaNavarra/">Clínica Universidad de Navarra</a> <a href="/CIMA_unav/">Cima Universidad de Navarra</a> <a href="/sehh_es/">@sehh_es</a> <a href="/_pethema/">PETHEMA</a>
Myeloma Patients Europe (@myelomaeurope) 's Twitter Profile Photo

Dr. Rakesh Popat presents early results on the trispecific antibody JNJ-5322: "response rate is similar to those obtained with #CART, but it is an off-the-shelf product"

Dr. Rakesh Popat presents early results on the trispecific antibody JNJ-5322: "response rate is similar to those obtained with #CART, but it is an off-the-shelf product"
Rakesh Popat (@drrakeshpopat) 's Twitter Profile Photo

Late breaking abstract 📢 Tec + Tal showing high response in EMD with strict central response assessments. Good to see dual antigen targeting making a difference in this high risk group. #mmsm #EHA2025

Late breaking abstract 📢
Tec + Tal showing high response in EMD with strict central response assessments. Good to see dual antigen targeting making a difference in this high risk group. #mmsm #EHA2025
Rakesh Popat (@drrakeshpopat) 's Twitter Profile Photo

Elran + DR for transplant ineligible myeloma patients. Impressive response rates with Q4W dosing of Elran. Looking forward to the treatment deescalation strategies in phase 3 #EHA2025

Elran + DR for transplant ineligible myeloma patients. Impressive response rates with Q4W dosing of Elran. Looking forward to the treatment deescalation strategies in phase 3 #EHA2025
IACH (@theiach) 's Twitter Profile Photo

𝗪𝗲 𝗮𝗿𝗲 𝗟𝗜𝗩𝗘 IACH 𝘱𝘰𝘴𝘵 𝘈𝘚𝘊𝘖 𝘌𝘏𝘈 𝘊𝘖𝘔𝘺 𝘳𝘰𝘶𝘯𝘥𝘵𝘢𝘣𝘭𝘦 𝘥𝘪𝘴𝘤𝘶𝘴𝘴𝘪𝘰𝘯 𝗗𝗲𝗱𝗶𝗰𝗮𝘁𝗲𝗱 𝘁𝗼 𝘁𝗵𝗲 𝗟𝗮𝘁𝗲𝘀𝘁 𝗠𝘆𝗲𝗹𝗼𝗺𝗮 𝗗𝗮𝘁𝗮 𝗮𝗻𝗱 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗣𝗿𝗮𝗰𝘁𝗶𝗰𝗲 𝗚𝘂𝗶𝗱𝗲𝗹𝗶𝗻𝗲𝘀 𝗙𝗥𝗘𝗘 𝗥𝗘𝗚𝗜𝗦𝗧𝗥𝗔𝗧𝗜𝗢𝗡 ⬇️⬇️

𝗪𝗲 𝗮𝗿𝗲 𝗟𝗜𝗩𝗘

<a href="/TheIACH/">IACH</a> 𝘱𝘰𝘴𝘵 𝘈𝘚𝘊𝘖 𝘌𝘏𝘈 𝘊𝘖𝘔𝘺 𝘳𝘰𝘶𝘯𝘥𝘵𝘢𝘣𝘭𝘦 𝘥𝘪𝘴𝘤𝘶𝘴𝘴𝘪𝘰𝘯
𝗗𝗲𝗱𝗶𝗰𝗮𝘁𝗲𝗱 𝘁𝗼 𝘁𝗵𝗲 𝗟𝗮𝘁𝗲𝘀𝘁 𝗠𝘆𝗲𝗹𝗼𝗺𝗮 𝗗𝗮𝘁𝗮 𝗮𝗻𝗱 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗣𝗿𝗮𝗰𝘁𝗶𝗰𝗲 𝗚𝘂𝗶𝗱𝗲𝗹𝗶𝗻𝗲𝘀

𝗙𝗥𝗘𝗘 𝗥𝗘𝗚𝗜𝗦𝗧𝗥𝗔𝗧𝗜𝗢𝗡
⬇️⬇️
Gareth Morgan (@drgarethmorgan1) 's Twitter Profile Photo

Thanks for posting Mike for posting and Linda for writing it’s critical to take this guidance seriously and to perform these test with good quality control to ensure patients receive optimum therapy - we should now move on to a molecular based approach

Myeloma Society (@myeloma_society) 's Twitter Profile Photo

Thank you to our colleagues at the Moroccan Society of Hematology for co-hosting our educational workshop! We had a great time learning with you. We hope to see you again soon.

Thank you to our colleagues at the Moroccan Society of Hematology for co-hosting our educational workshop! We had a great time learning with you. We hope to see you again soon.
Prof.Dr.Servet Altay (@drservetaltay) 's Twitter Profile Photo

New issue of the Balkan Medical Journal (SCI-E, Q1)  (Vol. 42, Issue 4) is now available. balkanmedicaljournal.org/content.php?id… #ProstatCancer #AntimyelomaTCell #LatticeRadiotherapy #PleuralNeedleBiopsy #TauPatology #TryglycerideGlucoseIndex #Atherosclerosis #p90RSKNrf2Pathway #BuriedBumperSy

New issue of the Balkan Medical Journal (SCI-E, Q1)  (Vol. 42, Issue 4) is now available. 
balkanmedicaljournal.org/content.php?id…
#ProstatCancer
#AntimyelomaTCell
#LatticeRadiotherapy
#PleuralNeedleBiopsy
#TauPatology
#TryglycerideGlucoseIndex
#Atherosclerosis
#p90RSKNrf2Pathway
#BuriedBumperSy
IACH (@theiach) 's Twitter Profile Photo

‼️𝘖𝘶𝘳 𝘭𝘢𝘵𝘦𝘴𝘵 IACH 𝘱𝘰𝘴𝘵 𝘈𝘚𝘊𝘖 𝘌𝘏𝘈 𝘊𝘖𝘔𝘺 𝘳𝘰𝘶𝘯𝘥𝘵𝘢𝘣𝘭𝘦 𝘥𝘪𝘴𝘤𝘶𝘴𝘴𝘪𝘰𝘯 𝗗𝗲𝗱𝗶𝗰𝗮𝘁𝗲𝗱 𝘁𝗼 𝘁𝗵𝗲 𝗟𝗮𝘁𝗲𝘀𝘁 𝗠𝘆𝗲𝗹𝗼𝗺𝗮 𝗗𝗮𝘁𝗮 𝗮𝗻𝗱 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗣𝗿𝗮𝗰𝘁𝗶𝗰𝗲 𝗚𝘂𝗶𝗱𝗲𝗹𝗶𝗻𝗲𝘀 📽️𝘕𝘰𝘸 𝘢𝘷𝘢𝘪𝘭𝘢𝘣𝘭𝘦 𝘰𝘯

Meral Beksac (@mbeksac56) 's Twitter Profile Photo

Yeni bir antiBCMA Miyelom imunoterapi ilacı daha onay aldı. Yakında hem yeni tanı hem de nüks hastalarda klinik çalışmaları ülkemize geliyor.